Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261
[email protected]


Usman “Oz” Azam, M.D.
Chief Executive Officer

Oz serves as Chief Executive Officer of Inspirna.

David Darst, M.B.A.

David co-leads Inspirna’s financing, corporate development, and drug development efforts.

Robert Wasserman, M.D.
Chief Medical Officer

Bob oversees clinical development of Inspirna’s first-in-class programs.

Isabel Kurth, Ph.D.
VP of Research

Isabel leads Inspirna’s research and target discovery efforts.

Stephen Wald, M.S.
SVP of Chemistry & Pharmaceutical Sciences

Steve is responsible for chemical, analytical and formulation development, and manufacturing scale-up, of Inspirna’s drug candidates.

Naftali Bechar, M.D.
SVP of Clinical Development

Naftali supports our CMO in managing clinical development of our novel drug candidates.

Kimberly Hoffman
VP of Clinical Operations

Kim leads overall clinical operations at Inspirna and is responsible for planning and execution of our clinical trials.

Corey Sohmer, M.B.A.
VP of Finance & Accounting

Corey brings to Inspirna more than 25 years of progressive leadership experience in finance and accounting.

Michael Szarek
Michael Szarek, Ph.D.
VP of Clinical & Regulatory Affairs

Michael leads clinical and regulatory affairs at Inspirna.

Anne Assmus, Ph.D.
Head of Business Development
Anne heads business development at Inspirna, where she focuses on strategic partnerships for the target discovery platform, preclinical and clinical stage programs.
Narayan Lebaka
Senior Director of Clinical Data Management

Narayan Lebaka heads Clinical Data Management at Inspirna. He is responsible for all clinical trial data deliverables through strategic partnerships with CROs.

Robert W. Busby, Ph.D.
Head of Clinical Pharmacology/ DMPK

Robert W. Busby, Ph.D. is an accomplished scientific and organizational leader with 25 years of pharmaceutical R&D experience.

Scott Spector
Head of Clinical Operations ompenaclid (RGX-202)

Scott is an accomplished clinical development executive with 20 years of pharmaceutical product development experience.

Steve Kaesshaefer
Head of Clinical Operations abequolixron (RGX-104)

Steve Kaesshaefer is an accomplished clinical operations executive with over 23 years of oncology drug development experience supporting several successful NDAs and IND filings.

Samantha Karpinski
Clinical Trial Associate

Samantha Karpinski is a Clinical Trial Associate as Inspirna.

Shugaku Takeda, PhD
Associate Director of Research

Shugaku leads Inspirna’s research and development efforts focused on biologics development.

Feng Wang
Senior Scientist

Feng Wang is a Senior Scientist leading research and development projects at Inspirna.

PuiChi Lo
Research Associate

PuiChi Lo is a Research Associate at Inspirna.

Daniel Schefer
Research Assistant

Daniel Schefer is currently a Research Assistant here at Inspirna.

Nayomi Thomas
Associate Director of HR and Legal

Nayomi Thomas is the Associate Director of HR and Legal of Inspirna, Inc.

Lily Yip
Executive Assistant

Lily Yip is the executive assistant who supports the Inspirna executive team members.